MedTrace Logo

Cytogenetic Study of Ocular Melanoma

NCT00344799 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 95

Last updated 2021-03-29

No results posted yet for this study

Summary

Patients who are diagnosed with choroidal melanoma and undergo I-125 plaque or enucleation surgery consent to participate in the study. A tumor sample taken during surgery is studied in the lab for genetic features. These features and features of subjects' clinical course are recorded. Analysis of the data may identify genetic features that are indicative of prognostic factors including risk of metastasis.

Conditions

  • Choroidal Melanoma

Sponsors & Collaborators

  • Jonsson Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Tara M McCannel, MD, PhD · Jules Stein Eye Institute, UCLA

  • Bradley R Straatsma, MD, JD · Jules Stein Eye Institute, UCLA

  • Lynn Gordon, MD, PhD · Jules Stein Eye Institute, UCLA

  • Ben Glasgow, MD · Jules Stein Eye Institute, UCLA

  • Nagesh P Rao, PhD · UCLA Pathology and Laboratory Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-08
Primary Completion
2020-10-23
Completion
2020-10-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00344799 on ClinicalTrials.gov